Dominick Angiolillo

Showing 1-8 of 8 articles

Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions

Zimarino M, Angiolillo D, Dangas G, Capodanno D, Barbato E, Hahn J, Giustino G, Watanabe H, Costa F, Cuisset T, Rossini R, Sibbing D, Burzotta F, Louvard Y, Shehab A, Renda G, Kimura T, Gwon H, Chen S, Costa R, Koo B, Storey R, Valgimigli M, Mehran R, Stankovic G

May 16, 2021 | 10.4244/EIJ-D-20-00885

De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

Capranzano P, Angiolillo D

August 9, 2019 | 10.4244/EIJV15I6A89

Coronary interventions

Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention

Rollini F, Franchi F, Angiolillo D

February 20, 2017 | 10.4244/EIJV12I14A276

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

Rossini R, Musumeci G, Visconti L, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, Bozzani A, Setacci C, Ravelli P, Crescini C, Staurenghi G, Pietro Scarone P, Francetti L, D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, Cremonesi A, Angiolillo D, Guagliumi G

May 20, 2014 | 10.4244/EIJV10I1A8

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jimenez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M

July 26, 2013 | 10.4244/EIJV9I3A54

Diabetes mellitus: the scary killer haunting silently

Capodanno D, Angiolillo D

April 12, 2010

Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome

Gomez-Moreno S, Sabaté M, Jimenez-Quevedo P, Vazquez P, Alfonso F, Angiolillo D, Hernández-Antolín R, Moreno R, Banuelos C, Escaned J, Macaya C

August 20, 2006

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease